Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News NextCure Inc NXTC

Healthcare Biotechnology
NextCure, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on advancing medicines that treat cancer patients that do not respond to, or have disease progression on, current therapies, through the use of differentiated mechanisms of actions including Antibody-Drug Conjugates (ADCs), antibodies, and proteins. The Company focuses on advancing therapies that leverage its... see more

Recent & Breaking News (NDAQ:NXTC)

NXTC INVESTOR ALERT: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NextCure Inc.

ACCESSWIRE IA October 1, 2020

DEADLINE REMINDER: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against NextCure, Inc. (NXTC) on Behalf of Investors

Business Wire October 1, 2020

NextCure Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In NextCure, Inc. To Contact The Firm

Newsfile October 1, 2020

SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against NextCure, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA September 30, 2020

NXTC Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies NextCure, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm

Newsfile September 30, 2020

IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against NextCure, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA September 29, 2020

NXTC CLASS ACTION DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NextCure Inc.

PR Newswire September 29, 2020

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action of a Securities Class Action Lawsuit Against NextCure, Inc. (NXTC)

Business Wire September 29, 2020

NXTC Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies NextCure, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm

ACCESSWIRE IA September 29, 2020

ROSEN, A LEADING LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against NextCure, Inc.; Encourages Investors with Losses in Excess of $100K to Contact the Firm - NXTC

PR Newswire September 28, 2020

SHAREHOLDER ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against NextCure, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA September 28, 2020

IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against NextCure, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA September 26, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NextCure, Inc. - NXTC

PR Newswire September 25, 2020

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against NextCure, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Business Wire September 25, 2020

NXTC SHAREHOLDER ALERT: Bernstein Liebhard Announces that a Securities Class Action Lawsuit has Been Filed Against NextCure Inc.

Business Wire September 25, 2020

SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against NextCure, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Business Wire September 24, 2020

IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against NextCure, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA September 24, 2020

Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of NextCure, Inc. (NXTC) Investors

Business Wire September 24, 2020

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of NextCure, Inc. (NXTC) Investors

Business Wire September 24, 2020

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of NextCure, Inc. (NXTC) Investors

Business Wire September 24, 2020